Laying Out Regulatory Requirements & Strategies to Achieve Representative D&I in ADC Clinical Trials

  • Explaining clinical trial processes and stressing the importance of regulatory requirements for clinical trial D&I
  • Breaking down FDORA requirements and the D&I landscape in the US to understand impact on clinical trial recruitment and study
  • Assessing differing strategies to achieve representative D&I across populations and locations